BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36879084)

  • 21. miR-200a/b/-429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer.
    Nilsen A; Hillestad T; Skingen VE; Aarnes EK; Fjeldbo CS; Hompland T; Evensen TS; Stokke T; Kristensen GB; Grallert B; Lyng H
    Mol Oncol; 2022 Mar; 16(6):1402-1419. PubMed ID: 35064630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The miR-200b/200a/429 cluster prevents metastasis and induces dormancy in a murine claudin-low mammary tumor cell line.
    Watson KL; Jones RA; Bruce A; Moorehead RA
    Exp Cell Res; 2018 Aug; 369(1):17-26. PubMed ID: 29702103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA methylation regulated microRNAs in human cervical cancer.
    Varghese VK; Shukla V; Kabekkodu SP; Pandey D; Satyamoorthy K
    Mol Carcinog; 2018 Mar; 57(3):370-382. PubMed ID: 29077234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
    Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
    Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells.
    Gao R; Zhang N; Yang J; Zhu Y; Zhang Z; Wang J; Xu X; Li Z; Liu X; Li Z; Li J; Kong C; Bi J
    J Exp Clin Cancer Res; 2019 Mar; 38(1):111. PubMed ID: 30823924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LINC00673 exerts oncogenic function in cervical cancer by negatively regulating miR-126-5p expression and activates PTEN/PI3K/AKT signaling pathway.
    Shi WJ; Liu H; Ge YF; Wu D; Tan YJ; Shen YC; Wang H; Xu H
    Cytokine; 2020 Dec; 136():155286. PubMed ID: 32950808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel Three-miRNA Signature Identified Using Bioinformatics Predicts Survival in Esophageal Carcinoma.
    Wu K; Zhang C; Zhang C; Dai D
    Biomed Res Int; 2020; 2020():5973082. PubMed ID: 32104700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism.
    Zhang HF; Alshareef A; Wu C; Li S; Jiao JW; Cao HH; Lai R; Xu LY; Li EM
    Oncotarget; 2015 Oct; 6(30):28949-60. PubMed ID: 26334393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. let-7i-5p, miR-181a-2-3p and EGF/PI3K/SOX2 axis coordinate to maintain cancer stem cell population in cervical cancer.
    Chhabra R
    Sci Rep; 2018 May; 8(1):7840. PubMed ID: 29777148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
    Liu H; Liu L; Zhu H
    J Comput Biol; 2019 Apr; 26(4):387-395. PubMed ID: 30762435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circ_0,007,331 Promotes the PTX Resistance and Progression of Breast Cancer via miR-200b-3p/ANLN.
    Yang C; Liu L; Gao C; Zhang G; Zhang Y; Zhang S; Li J; Liu Y
    J Surg Res; 2022 Nov; 279():619-632. PubMed ID: 35926312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory Breast Carcinoma: Elevated microRNA miR-181b-5p and Reduced miR-200b-3p, miR-200c-3p, and miR-203a-3p Expression as Potential Biomarkers with Diagnostic Value.
    Fahim SA; Abdullah MS; Espinoza-Sánchez NA; Hassan H; Ibrahim AM; Ahmed SH; Shakir G; Badawy MA; Zakhary NI; Greve B; El-Shinawi M; Götte M; Ibrahim SA
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32708601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-200b and cancer/testis antigen CAGE form a feedback loop to regulate the invasion and tumorigenic and angiogenic responses of a cancer cell line to microtubule-targeting drugs.
    Kim Y; Park D; Kim H; Choi M; Lee H; Lee YS; Choe J; Kim YM; Jeoung D
    J Biol Chem; 2013 Dec; 288(51):36502-18. PubMed ID: 24174534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
    Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
    Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of potential miRNAs and candidate genes of cervical intraepithelial neoplasia by bioinformatic analysis.
    Yang C; Xu X; Jin H
    Eur J Gynaecol Oncol; 2016 Aug; 37(4):469-473. PubMed ID: 29894068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
    Li C; Zheng X; Li W; Bai F; Lyu J; Meng QH
    BMC Cancer; 2018 Jan; 18(1):61. PubMed ID: 29316891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of an enhancer that increases miR-200b~200a~429 gene expression in breast cancer cells.
    Attema JL; Bert AG; Lim YY; Kolesnikoff N; Lawrence DM; Pillman KA; Smith E; Drew PA; Khew-Goodall Y; Shannon F; Goodall GJ
    PLoS One; 2013; 8(9):e75517. PubMed ID: 24086551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A ceRNA network of BBOX1-AS1-hsa-miR-125b-5p/hsa-miR-125a-5p-CDKN2A shows prognostic value in cervical cancer.
    Wang T; Zhang XD; Hua KQ
    Taiwan J Obstet Gynecol; 2021 Mar; 60(2):253-261. PubMed ID: 33678324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.
    Li X; Roslan S; Johnstone CN; Wright JA; Bracken CP; Anderson M; Bert AG; Selth LA; Anderson RL; Goodall GJ; Gregory PA; Khew-Goodall Y
    Oncogene; 2014 Jul; 33(31):4077-88. PubMed ID: 24037528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.